866-997-4948(US-Canada Toll Free)

Global Opioids Agonist Drugs Sales Market Report 2018

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 111 Pages

This report studies the global Opioids Agonist Drugs market status and forecast, categorizes the global Opioids Agonist Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
The global Opioids Agonist Drugs market is valued at 18600 million US$ in 2017 and will reach 25900 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2018-2025.

The major players covered in this report
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Pain Management
Cough Treatment
Diarrhea Treatment

The study objectives of this report are:
To analyze and study the global Opioids Agonist Drugs sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Opioids Agonist Drugs players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Opioids Agonist Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Opioids Agonist Drugs Manufacturers
Opioids Agonist Drugs Distributors/Traders/Wholesalers
Opioids Agonist Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Opioids Agonist Drugs market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Opioids Agonist Drugs Sales Market Report 2018
1 Opioids Agonist Drugs Market Overview
1.1 Product Overview and Scope of Opioids Agonist Drugs
1.2 Classification of Opioids Agonist Drugs by Product Category
1.2.1 Global Opioids Agonist Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Opioids Agonist Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Codeine
1.2.4 Fentanyl
1.2.5 Meperidine
1.2.6 Methadone
1.2.7 Morphine
1.2.8 Hydrocodone
1.3 Global Opioids Agonist Drugs Market by Application/End Users
1.3.1 Global Opioids Agonist Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Pain Management
1.3.2 Cough Treatment
1.3.3 Diarrhea Treatment
1.4 Global Opioids Agonist Drugs Market by Region
1.4.1 Global Opioids Agonist Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Opioids Agonist Drugs Status and Prospect (2013-2025)
1.4.3 Europe Opioids Agonist Drugs Status and Prospect (2013-2025)
1.4.4 China Opioids Agonist Drugs Status and Prospect (2013-2025)
1.4.5 Japan Opioids Agonist Drugs Status and Prospect (2013-2025)
1.4.6 Southeast Asia Opioids Agonist Drugs Status and Prospect (2013-2025)
1.4.7 India Opioids Agonist Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Opioids Agonist Drugs (2013-2025)
1.5.1 Global Opioids Agonist Drugs Sales and Growth Rate (2013-2025)
1.5.2 Global Opioids Agonist Drugs Revenue and Growth Rate (2013-2025)

2 Global Opioids Agonist Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Opioids Agonist Drugs Market Competition by Players/Suppliers
2.1.1 Global Opioids Agonist Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Opioids Agonist Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Opioids Agonist Drugs (Volume and Value) by Type
2.2.1 Global Opioids Agonist Drugs Sales and Market Share by Type (2013-2018)
2.2.2 Global Opioids Agonist Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Opioids Agonist Drugs (Volume and Value) by Region
2.3.1 Global Opioids Agonist Drugs Sales and Market Share by Region (2013-2018)
2.3.2 Global Opioids Agonist Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Opioids Agonist Drugs (Volume) by Application

3 United States Opioids Agonist Drugs (Volume, Value and Sales Price)
3.1 United States Opioids Agonist Drugs Sales and Value (2013-2018)
3.1.1 United States Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
3.1.2 United States Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
3.1.3 United States Opioids Agonist Drugs Sales Price Trend (2013-2018)
3.2 United States Opioids Agonist Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Opioids Agonist Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Opioids Agonist Drugs Sales Volume and Market Share by Application (2013-2018)

4 Europe Opioids Agonist Drugs (Volume, Value and Sales Price)
4.1 Europe Opioids Agonist Drugs Sales and Value (2013-2018)
4.1.1 Europe Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
4.1.2 Europe Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
4.1.3 Europe Opioids Agonist Drugs Sales Price Trend (2013-2018)
4.2 Europe Opioids Agonist Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Opioids Agonist Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Opioids Agonist Drugs Sales Volume and Market Share by Application (2013-2018)

5 China Opioids Agonist Drugs (Volume, Value and Sales Price)
5.1 China Opioids Agonist Drugs Sales and Value (2013-2018)
5.1.1 China Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
5.1.2 China Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
5.1.3 China Opioids Agonist Drugs Sales Price Trend (2013-2018)
5.2 China Opioids Agonist Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Opioids Agonist Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Opioids Agonist Drugs Sales Volume and Market Share by Application (2013-2018)

6 Japan Opioids Agonist Drugs (Volume, Value and Sales Price)
6.1 Japan Opioids Agonist Drugs Sales and Value (2013-2018)
6.1.1 Japan Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.1.2 Japan Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
6.1.3 Japan Opioids Agonist Drugs Sales Price Trend (2013-2018)
6.2 Japan Opioids Agonist Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Opioids Agonist Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Opioids Agonist Drugs Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Opioids Agonist Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Opioids Agonist Drugs Sales and Value (2013-2018)
7.1.1 Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Opioids Agonist Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Opioids Agonist Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Opioids Agonist Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Opioids Agonist Drugs Sales Volume and Market Share by Application (2013-2018)

8 India Opioids Agonist Drugs (Volume, Value and Sales Price)
8.1 India Opioids Agonist Drugs Sales and Value (2013-2018)
8.1.1 India Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
8.1.2 India Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
8.1.3 India Opioids Agonist Drugs Sales Price Trend (2013-2018)
8.2 India Opioids Agonist Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Opioids Agonist Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Opioids Agonist Drugs Sales Volume and Market Share by Application (2013-2018)

9 Global Opioids Agonist Drugs Players/Suppliers Profiles and Sales Data
9.1 Purdue Pharma
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Opioids Agonist Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Titan pharmaceuticals
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Opioids Agonist Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Boehringer Ingelheim
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Opioids Agonist Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Janssen Pharmaceuticals, Inc
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Opioids Agonist Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Sanofi
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Opioids Agonist Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Sanofi Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Sun Pharmaceuticals
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Opioids Agonist Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Mallinckrodt Pharmaceuticals
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Opioids Agonist Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Egalet Corporation
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Opioids Agonist Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Endo Pharmaceuticals Inc.
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Opioids Agonist Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Allergan, Plc
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Opioids Agonist Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Pfizer Inc

10 Opioids Agonist Drugs Maufacturing Cost Analysis
10.1 Opioids Agonist Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Opioids Agonist Drugs
10.3 Manufacturing Process Analysis of Opioids Agonist Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Opioids Agonist Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Opioids Agonist Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Opioids Agonist Drugs Market Forecast (2018-2025)
14.1 Global Opioids Agonist Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Opioids Agonist Drugs Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Opioids Agonist Drugs Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Opioids Agonist Drugs Price and Trend Forecast (2018-2025)
14.2 Global Opioids Agonist Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Opioids Agonist Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Opioids Agonist Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Opioids Agonist Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Opioids Agonist Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Opioids Agonist Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Opioids Agonist Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Opioids Agonist Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Opioids Agonist Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Opioids Agonist Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Opioids Agonist Drugs Sales Forecast by Type (2018-2025)
14.3.2 Global Opioids Agonist Drugs Revenue Forecast by Type (2018-2025)
14.3.3 Global Opioids Agonist Drugs Price Forecast by Type (2018-2025)
14.4 Global Opioids Agonist Drugs Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Opioids Agonist Drugs
Figure Global Opioids Agonist Drugs Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Opioids Agonist Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Codeine Product Picture
Figure Fentanyl Product Picture
Figure Meperidine Product Picture
Figure Methadone Product Picture
Figure Morphine Product Picture
Figure Hydrocodone Product Picture
Figure Global Opioids Agonist Drugs Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Opioids Agonist Drugs by Application in 2017
Figure Pain Management Examples
Table Key Downstream Customer in Pain Management
Figure Cough Treatment Examples
Table Key Downstream Customer in Cough Treatment
Figure Diarrhea Treatment Examples
Table Key Downstream Customer in Diarrhea Treatment
Figure Global Opioids Agonist Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Opioids Agonist Drugs Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Opioids Agonist Drugs Sales Volume (K Units) (2013-2018)
Table Global Opioids Agonist Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Opioids Agonist Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Opioids Agonist Drugs Sales Share by Players/Suppliers
Figure 2017 Opioids Agonist Drugs Sales Share by Players/Suppliers
Figure Global Opioids Agonist Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Opioids Agonist Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Opioids Agonist Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Opioids Agonist Drugs Revenue Share by Players
Table 2017 Global Opioids Agonist Drugs Revenue Share by Players
Table Global Opioids Agonist Drugs Sales (K Units) and Market Share by Type (2013-2018)
Table Global Opioids Agonist Drugs Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Opioids Agonist Drugs by Type (2013-2018)
Figure Global Opioids Agonist Drugs Sales Growth Rate by Type (2013-2018)
Table Global Opioids Agonist Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Opioids Agonist Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Opioids Agonist Drugs by Type (2013-2018)
Figure Global Opioids Agonist Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Opioids Agonist Drugs Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Opioids Agonist Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Opioids Agonist Drugs by Region (2013-2018)
Figure Global Opioids Agonist Drugs Sales Growth Rate by Region in 2017
Table Global Opioids Agonist Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Opioids Agonist Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Opioids Agonist Drugs by Region (2013-2018)
Figure Global Opioids Agonist Drugs Revenue Growth Rate by Region in 2017
Table Global Opioids Agonist Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Opioids Agonist Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Opioids Agonist Drugs by Region (2013-2018)
Figure Global Opioids Agonist Drugs Revenue Market Share by Region in 2017
Table Global Opioids Agonist Drugs Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Opioids Agonist Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Opioids Agonist Drugs by Application (2013-2018)
Figure Global Opioids Agonist Drugs Sales Market Share by Application (2013-2018)
Figure United States Opioids Agonist Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure United States Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Opioids Agonist Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table United States Opioids Agonist Drugs Sales Volume (K Units) by Players (2013-2018)
Table United States Opioids Agonist Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Opioids Agonist Drugs Sales Volume Market Share by Players in 2017
Table United States Opioids Agonist Drugs Sales Volume (K Units) by Type (2013-2018)
Table United States Opioids Agonist Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Opioids Agonist Drugs Sales Volume Market Share by Type in 2017
Table United States Opioids Agonist Drugs Sales Volume (K Units) by Application (2013-2018)
Table United States Opioids Agonist Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Opioids Agonist Drugs Sales Volume Market Share by Application in 2017
Figure Europe Opioids Agonist Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Opioids Agonist Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Opioids Agonist Drugs Sales Volume (K Units) by Players (2013-2018)
Table Europe Opioids Agonist Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Opioids Agonist Drugs Sales Volume Market Share by Players in 2017
Table Europe Opioids Agonist Drugs Sales Volume (K Units) by Type (2013-2018)
Table Europe Opioids Agonist Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Opioids Agonist Drugs Sales Volume Market Share by Type in 2017
Table Europe Opioids Agonist Drugs Sales Volume (K Units) by Application (2013-2018)
Table Europe Opioids Agonist Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Opioids Agonist Drugs Sales Volume Market Share by Application in 2017
Figure China Opioids Agonist Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure China Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Opioids Agonist Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table China Opioids Agonist Drugs Sales Volume (K Units) by Players (2013-2018)
Table China Opioids Agonist Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Opioids Agonist Drugs Sales Volume Market Share by Players in 2017
Table China Opioids Agonist Drugs Sales Volume (K Units) by Type (2013-2018)
Table China Opioids Agonist Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Opioids Agonist Drugs Sales Volume Market Share by Type in 2017
Table China Opioids Agonist Drugs Sales Volume (K Units) by Application (2013-2018)
Table China Opioids Agonist Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Opioids Agonist Drugs Sales Volume Market Share by Application in 2017
Figure Japan Opioids Agonist Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Opioids Agonist Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Opioids Agonist Drugs Sales Volume (K Units) by Players (2013-2018)
Table Japan Opioids Agonist Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Opioids Agonist Drugs Sales Volume Market Share by Players in 2017
Table Japan Opioids Agonist Drugs Sales Volume (K Units) by Type (2013-2018)
Table Japan Opioids Agonist Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Opioids Agonist Drugs Sales Volume Market Share by Type in 2017
Table Japan Opioids Agonist Drugs Sales Volume (K Units) by Application (2013-2018)
Table Japan Opioids Agonist Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Opioids Agonist Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Opioids Agonist Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Opioids Agonist Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Opioids Agonist Drugs Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Opioids Agonist Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Opioids Agonist Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Opioids Agonist Drugs Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Opioids Agonist Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Opioids Agonist Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Opioids Agonist Drugs Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Opioids Agonist Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Opioids Agonist Drugs Sales Volume Market Share by Application in 2017
Figure India Opioids Agonist Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure India Opioids Agonist Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Opioids Agonist Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table India Opioids Agonist Drugs Sales Volume (K Units) by Players (2013-2018)
Table India Opioids Agonist Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Opioids Agonist Drugs Sales Volume Market Share by Players in 2017
Table India Opioids Agonist Drugs Sales Volume (K Units) by Type (2013-2018)
Table India Opioids Agonist Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Opioids Agonist Drugs Sales Volume Market Share by Type in 2017
Table India Opioids Agonist Drugs Sales Volume (K Units) by Application (2013-2018)
Table India Opioids Agonist Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Opioids Agonist Drugs Sales Volume Market Share by Application in 2017
Table Purdue Pharma Basic Information List
Table Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Purdue Pharma Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Purdue Pharma Opioids Agonist Drugs Sales Global Market Share (2013-2018)
Figure Purdue Pharma Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Titan pharmaceuticals Basic Information List
Table Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Titan pharmaceuticals Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Titan pharmaceuticals Opioids Agonist Drugs Sales Global Market Share (2013-2018)
Figure Titan pharmaceuticals Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Opioids Agonist Drugs Sales Global Market Share (2013-2018
Figure Boehringer Ingelheim Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Janssen Pharmaceuticals, Inc Basic Information List
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales Global Market Share (2013-2018)
Figure Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Opioids Agonist Drugs Sales Global Market Share (2013-2018)
Figure Sanofi Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Sun Pharmaceuticals Basic Information List
Table Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sun Pharmaceuticals Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Sun Pharmaceuticals Opioids Agonist Drugs Sales Global Market Share (2013-2018
Figure Sun Pharmaceuticals Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Mallinckrodt Pharmaceuticals Basic Information List
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales Global Market Share (2013-2018)
Figure Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Egalet Corporation Basic Information List
Table Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Egalet Corporation Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Egalet Corporation Opioids Agonist Drugs Sales Global Market Share (2013-2018
Figure Egalet Corporation Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Endo Pharmaceuticals Inc. Basic Information List
Table Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales Global Market Share (2013-2018)
Figure Endo Pharmaceuticals Inc. Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Allergan, Plc Basic Information List
Table Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan, Plc Opioids Agonist Drugs Sales Growth Rate (2013-2018)
Figure Allergan, Plc Opioids Agonist Drugs Sales Global Market Share (2013-2018)
Figure Allergan, Plc Opioids Agonist Drugs Revenue Global Market Share (2013-2018)
Table Pfizer Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioids Agonist Drugs
Figure Manufacturing Process Analysis of Opioids Agonist Drugs
Figure Opioids Agonist Drugs Industrial Chain Analysis
Table Raw Materials Sources of Opioids Agonist Drugs Major Players in 2017
Table Major Buyers of Opioids Agonist Drugs
Table Distributors/Traders List
Figure Global Opioids Agonist Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Opioids Agonist Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Opioids Agonist Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Opioids Agonist Drugs Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Opioids Agonist Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Opioids Agonist Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Opioids Agonist Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Opioids Agonist Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Opioids Agonist Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Opioids Agonist Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Opioids Agonist Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Opioids Agonist Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Opioids Agonist Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Opioids Agonist Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Opioids Agonist Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Opioids Agonist Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Opioids Agonist Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Opioids Agonist Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Opioids Agonist Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Opioids Agonist Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Opioids Agonist Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Opioids Agonist Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure Global Opioids Agonist Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Opioids Agonist Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Opioids Agonist Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Opioids Agonist Drugs Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Opioids Agonist Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure Global Opioids Agonist Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *